Scientists devise stem line with sickle cell variation

05/29/2008 | Washington Post (tiered subscription model), The

U.S. researchers were able to reprogram adult cells into embryonic-like stem cell lines that contain the mutation linked to sickle cell anemia within 12 to 14 days using four genes and SV40 large T antigen, a viral protein. "Having these new cell lines available might enable some bigger projects, like screening for potential drugs," one of the researchers said.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ